The Cobra PzF stent is a first-in-class nanocoated coronary stent that is FDA-approved for improving coronary luminal diameter in patients, including those with diabetes mellitus, with symptomatic ischemic heart disease due to de novo lesions in native coronary arteries. The Cobra PzF stent utilizes a proprietary Polyzene-F nanothin polymer coating on a thin strut, open cell cobalt chromium stent platform. The Cobra PzF stent is not a drug eluting stent. The Polyzene-F nanocoating is a proprietary, ultra-thin, durable and elastic polymer that is designed to be highly biocompatible and act as a barrier between the stent metal, blood and circulating elements.
If you have a Hayes login, click here to view the full report on the Knowledge Center.